{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:10:43Z","timestamp":1794319843199,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20413"],"award-info":[{"award-number":["U21A20413"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012247","name":"Program of Shanghai Academic Research Leader","doi-asserted-by":"publisher","award":["21XD1403500"],"award-info":[{"award-number":["21XD1403500"]}],"id":[{"id":"10.13039\/501100012247","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Qi Huang Scholar"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic disorders have become one of the global medical problems. Due to the complexity of its pathogenesis, there is still no effective treatment. Bile acids (BAs) and gut microbiota (GM) have been proved to be closely related to host metabolism, which could be important targets for metabolic disorders. Zhi-Kang-Yin (ZKY) is a traditional Chinese medicine (TCM) formula developed by the research team according to theory of TCM and has been shown to improve metabolism in clinic. However, the underlying mechanisms are unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim of the study<\/jats:title>\n                <jats:p>This study aimed to investigate the potential mechanisms of the beneficial effect of ZKY on metabolism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>High-fat diet (HFD)-fed mice were treated with and without ZKY. The glucose and lipid metabolism-related indexes were measured. BA profile, GM composition and hepatic transcriptome were then investigated to analyze the changes of BAs, GM, and hepatic gene expression. Moreover, the relationship between GM and BAs was identified with functional gene quantification and ex vivo fermentation experiment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ZKY reduced weight gain and lipid levels in both liver and serum, attenuated hepatic steatosis and improved glucose tolerance in HFD-fed mice. BA profile detection showed that ZKY changed the composition of BAs and increased the proportion of unconjugated BAs and non-12-OH BAs. Hepatic transcriptomic analysis revealed fatty acid metabolism and BA biosynthesis related pathways were regulated. In addition, ZKY significantly changed the structure of GM and upregulated the gene copy number of bacterial bile salt hydrolase. Meanwhile, ZKY directly promoted the growth of <jats:italic>Bifidobacterium<\/jats:italic>, which is a well-known bile salt hydrolase<jats:bold>-<\/jats:bold>producing genus. The ex vivo co-culture experiment with gut microbiota and BAs demonstrated that the changes of BAs profile in ZKY group were mediated by ZKY-shifted GM, which led to increased expression of genes associated with fatty acid degradation in the liver.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study indicated that the effect of ZKY on improving metabolism is associated with the modulation of GM-BAs axis, especially, by upregulating the abundance of bile salt hydrolase-expression bacteria and increasing the levels of unconjugated BAs. This study indicates that GM-BAs axis might be an important pathway for improving metabolic disorders by ZKY.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13020-024-01021-w","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T16:02:22Z","timestamp":1729267342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Zhi-Kang-Yin formula attenuates high-fat diet-induced metabolic disorders through modulating gut microbiota-bile acids axis in mice"],"prefix":"10.1186","volume":"19","author":[{"given":"Yifan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weize","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houkai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"3","key":"1021_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew NWS, Ng CH, Tan DJH, Kong G, Lin C, Chin YH, et al. The global burden of metabolic disease: data from 2000 to 2019. Cell Metab. 2023;35(3):414-428.e3.","journal-title":"Cell Metab"},{"issue":"2","key":"1021_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1021_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"1021_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/ijms20010128","volume":"20","author":"H Xu","year":"2018","unstructured":"Xu H, Li X, Adams H, Kubena K, Guo S. Etiology of metabolic syndrome and dietary intervention. Int J Mol Sci. 2018;20(1):128.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1021_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393.","journal-title":"Nat Rev Drug Discov"},{"key":"1021_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","volume":"104","author":"BL Copple","year":"2016","unstructured":"Copple BL, Li T. Pharmacology of bile acid receptors: evolution of bile acids from simple detergents to complex signaling molecules. Pharmacol Res. 2016;104:9\u201321.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1021_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/hep.28709","volume":"65","author":"JP Arab","year":"2017","unstructured":"Arab JP, Karpen SJ, Dawson PA, Arrese M, Trauner M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology. 2017;65(1):350\u201362.","journal-title":"Hepatology"},{"issue":"2","key":"1021_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1021_CR9","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","volume":"14","author":"J Zhong","year":"2023","unstructured":"Zhong J, He X, Gao X, Liu Q, Zhao Y, Hong Y, et al. Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPAR\u03b1 nucleus-cytoplasm shuttling. Nat Commun. 2023;14(1):5451.","journal-title":"Nat Commun"},{"issue":"10","key":"1021_CR10","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","volume":"35","author":"J Kuang","year":"2023","unstructured":"Kuang J, Wang J, Li Y, Li M, Zhao M, Ge K, et al. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis. Cell Metab. 2023;35(10):1752-1766.e8.","journal-title":"Cell Metab"},{"issue":"1","key":"1021_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42.","journal-title":"Genome Med"},{"key":"1021_CR12","doi-asserted-by":"publisher","first-page":"32002","DOI":"10.1038\/srep32002","volume":"6","author":"B Wang","year":"2016","unstructured":"Wang B, Jiang X, Cao M, Ge J, Bao Q, Tang L, et al. Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease. Sci Rep. 2016;6:32002.","journal-title":"Sci Rep"},{"issue":"1","key":"1021_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55\u201371.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"1021_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"key":"1021_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153487","volume":"83","author":"F Wu","year":"2021","unstructured":"Wu F, Shao Q, Xia Q, Hu M, Zhao Y, Wang D, et al. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K\/Akt\/FoxO1 signaling pathway. Phytomedicine. 2021;83: 153487.","journal-title":"Phytomedicine"},{"key":"1021_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153812","volume":"93","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang L, Ren P, Yang Y, Li S, Qin X, et al. Qing-Xue-Xiao-Zhi formula attenuates atherosclerosis by inhibiting macrophage lipid accumulation and inflammatory response via TLR4\/MyD88\/NF-\u03baB pathway regulation. Phytomedicine. 2021;93: 153812.","journal-title":"Phytomedicine"},{"issue":"9","key":"1021_CR17","first-page":"669","volume":"20","author":"W-Y Su","year":"2022","unstructured":"Su W-Y, Fan M-L, Li Y, Hu J-N, Cai E-B, Zhu H-Y, et al. 20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt\/FOXO1 pathway. Chin J Nat Med. 2022;20(9):669\u201378.","journal-title":"Chin J Nat Med"},{"issue":"6","key":"1021_CR18","first-page":"401","volume":"19","author":"S Cui","year":"2021","unstructured":"Cui S, Pan X-J, Ge C-L, Guo Y-T, Zhang P-F, Yan T-T, et al. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor \u03b1. Chin J Nat Med. 2021;19(6):401\u201311.","journal-title":"Chin J Nat Med"},{"issue":"2","key":"1021_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4103\/CMAC.CMAC_21_19","volume":"2","author":"G Korio","year":"2019","unstructured":"Korio G. Treatment of obesity with western medicine and traditional medicine: based on pubmed and science direct databases. Chin Med Cult. 2019;2(2):99\u2013104.","journal-title":"Chin Med Cult"},{"issue":"09","key":"1021_CR20","first-page":"56","volume":"29","author":"Y Xiong","year":"2013","unstructured":"Xiong Y, Wang Y, Chen B, Liu P. Efficacy of Zhikangyin on 35 cases of non-alcoholic fatty liver disease. Hunan J Chin Med. 2013;29(09):56\u20138.","journal-title":"Hunan J Chin Med"},{"issue":"01","key":"1021_CR21","first-page":"78","volume":"31","author":"Y Xiong","year":"2015","unstructured":"Xiong Y, Zhang Z, Liu P, Wang Y. Efficacy of Chaowei Zhikangyin in treatment of rat model of non-alcoholic fatty liver disease. J Clin Hepatol. 2015;31(01):78\u201381.","journal-title":"J Clin Hepatol"},{"key":"1021_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112984","volume":"150","author":"C Lin","year":"2022","unstructured":"Lin C, Yu B, Liu X, Chen L, Zhang Z, Ye W, et al. Obeticholic acid inhibits hepatic fatty acid uptake independent of FXR in mouse. Biomed Pharmacother. 2022;150: 112984.","journal-title":"Biomed Pharmacother"},{"key":"1021_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.914079","volume":"9","author":"H Li","year":"2022","unstructured":"Li H, Xi Y, Liu H, Xin X. Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation. Front Nutr. 2022;9: 914079.","journal-title":"Front Nutr"},{"key":"1021_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102582","volume":"59","author":"A Zhuge","year":"2023","unstructured":"Zhuge A, Li S, Yuan Y, Han S, Xia J, Wang Q, et al. Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice. Redox Biol. 2023;59: 102582.","journal-title":"Redox Biol"},{"issue":"1","key":"1021_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41522-023-00399-z","volume":"9","author":"J Liu","year":"2023","unstructured":"Liu J, Sun J, Yu J, Chen H, Zhang D, Zhang T, et al. Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism. NPJ Biofilms Microbiomes. 2023;9(1):29.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"1021_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hep.29721","volume":"68","author":"ZM Younossi","year":"2018","unstructured":"Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, et al. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology. 2018;68(1):349\u201360.","journal-title":"Hepatology"},{"key":"1021_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.923377","volume":"9","author":"W Zhu","year":"2022","unstructured":"Zhu W, Hong Y, Li Y, Li Y, Zhong J, He X, et al. Microbial and transcriptomic profiling reveals diet-related alterations of metabolism in metabolic disordered mice. Front Nutr. 2022;9: 923377.","journal-title":"Front Nutr"},{"issue":"1","key":"1021_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.21037\/hbsn-20-671","volume":"10","author":"L Sheng","year":"2021","unstructured":"Sheng L, Jena PK, Hu Y, Wan Y-JY. Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex. Hepatobiliary Surg Nutr. 2021;10(1):31\u201348.","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"1","key":"1021_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s43705-023-00245-5","volume":"3","author":"X Tao","year":"2023","unstructured":"Tao X, Huang W, Pan L, Sheng L, Qin Y, Chen L, et al. Optimizing ex vivo culture conditions to study human gut microbiome. ISME Commun. 2023;3(1):38.","journal-title":"ISME Commun"},{"issue":"6","key":"1021_CR30","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/microorganisms9061122","volume":"9","author":"M Bourgin","year":"2021","unstructured":"Bourgin M, Kriaa A, Mkaouar H, Mariaule V, Jablaoui A, Maguin E, Rhimi M. Bile salt hydrolases: at the crossroads of microbiota and human health. Microorganisms. 2021;9(6):1122.","journal-title":"Microorganisms"},{"issue":"1","key":"1021_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song Z, Cai Y, Lao X, Wang X, Lin X, Cui Y, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome. 2019;7(1):9.","journal-title":"Microbiome"},{"issue":"1","key":"1021_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.chom.2020.05.005","volume":"28","author":"MT Sorbara","year":"2020","unstructured":"Sorbara MT, Littmann ER, Fontana E, Moody TU, Kohout CE, Gjonbalaj M, et al. Functional and genomic variation between human-derived isolates of lachnospiraceae reveals inter- and intra-species diversity. Cell Host Microbe. 2020;28(1):134-146.e4.","journal-title":"Cell Host Microbe"},{"key":"1021_CR33","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/ncomms2852","volume":"4","author":"I Kimura","year":"2013","unstructured":"Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829.","journal-title":"Nat Commun"},{"issue":"4","key":"1021_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","volume":"8","author":"M Vacca","year":"2020","unstructured":"Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The controversial role of human gut lachnospiraceae. Microorganisms. 2020;8(4):573.","journal-title":"Microorganisms"},{"issue":"1","key":"1021_CR35","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1038\/s41467-022-32015-7","volume":"13","author":"K Hosomi","year":"2022","unstructured":"Hosomi K, Saito M, Park J, Murakami H, Shibata N, Ando M, et al. Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota. Nat Commun. 2022;13(1):4477.","journal-title":"Nat Commun"},{"issue":"1","key":"1021_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1875796","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, et al. Blautia-a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1\u201321.","journal-title":"Gut Microbes"},{"key":"1021_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fcimb.2015.00084","volume":"5","author":"NO Kaakoush","year":"2015","unstructured":"Kaakoush NO. Insights into the role of erysipelotrichaceae in the human host. Front Cell Infect Microbiol. 2015;5:84.","journal-title":"Front Cell Infect Microbiol"},{"issue":"20","key":"1021_CR38","doi-asserted-by":"publisher","first-page":"10210","DOI":"10.1039\/D1FO02288A","volume":"12","author":"S Li","year":"2021","unstructured":"Li S, Zhuge A, Wang K, Lv L, Bian X, Yang L, et al. Ketogenic diet aggravates colitis, impairs intestinal barrier and alters gut microbiota and metabolism in DSS-induced mice. Food Funct. 2021;12(20):10210\u201325.","journal-title":"Food Funct"},{"key":"1021_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122231","volume":"334","author":"X Ye","year":"2023","unstructured":"Ye X, Sun P, Lao S, Wen M, Zheng R, Lin Y, et al. Fgf21-Dubosiella axis mediates the protective effects of exercise against NAFLD development. Life Sci. 2023;334: 122231.","journal-title":"Life Sci"},{"key":"1021_CR40","doi-asserted-by":"publisher","first-page":"1090955","DOI":"10.3389\/fphar.2022.1090955","volume":"13","author":"X-L Chen","year":"2022","unstructured":"Chen X-L, Cai K, Zhang W, Su S-L, Zhao L-H, Qiu L-P, Duan J-A. Bear bile powder ameliorates type 2 diabetes via modulation of metabolic profiles, gut microbiota, and metabolites. Front Pharmacol. 2022;13:1090955.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1021_CR41","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev. 2021;101(2):683\u2013731.","journal-title":"Physiol Rev"},{"issue":"5","key":"1021_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13238-020-00804-9","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia W, Wei M, Rajani C, Zheng X. Targeting the alternative bile acid synthetic pathway for metabolic diseases. Protein Cell. 2021;12(5):411\u201325.","journal-title":"Protein Cell"},{"issue":"21","key":"1021_CR43","doi-asserted-by":"publisher","first-page":"8613","DOI":"10.1021\/acs.analchem.4c00676","volume":"96","author":"A-Q Zhao","year":"2024","unstructured":"Zhao A-Q, Zheng J-Y, Chen C, Liu L-F, Xin G-Z. Enzyme-driven LC-HRMS approach for specific recognition of 12\u03b1-hydroxy bile acids. Anal Chem. 2024;96(21):8613\u201321.","journal-title":"Anal Chem"},{"issue":"1","key":"1021_CR44","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","volume":"10","author":"F Huang","year":"2019","unstructured":"Huang F, Zheng X, Ma X, Jiang R, Zhou W, Zhou S, et al. Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism. Nat Commun. 2019;10(1):4971.","journal-title":"Nat Commun"},{"issue":"12","key":"1021_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167680","volume":"11","author":"K-H Seo","year":"2016","unstructured":"Seo K-H, Bartley GE, Tam C, Kim H-S, Kim D-H, Chon J-W, et al. Chardonnay grape seed flour ameliorates hepatic steatosis and insulin resistance via altered hepatic gene expression for oxidative stress, inflammation, and lipid and ceramide synthesis in diet-induced obese mice. PLoS ONE. 2016;11(12): e0167680.","journal-title":"PLoS ONE"},{"issue":"1","key":"1021_CR46","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1038\/s41598-022-20838-9","volume":"12","author":"W Iwasaki","year":"2022","unstructured":"Iwasaki W, Yoshida R, Liu H, Hori S, Otsubo Y, Tanaka Y, et al. The ratio of 12\u03b1 to non-12-hydroxylated bile acids reflects hepatic triacylglycerol accumulation in high-fat diet-fed C57BL\/6J mice. Sci Rep. 2022;12(1):16707.","journal-title":"Sci Rep"},{"key":"1021_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108412","volume":"83","author":"S Hori","year":"2020","unstructured":"Hori S, Abe T, Lee DG, Fukiya S, Yokota A, Aso N, et al. Association between 12\u03b1-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet. J Nutr Biochem. 2020;83: 108412.","journal-title":"J Nutr Biochem"},{"issue":"12","key":"1021_CR48","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.2337\/db13-0639","volume":"62","author":"RA Haeusler","year":"2013","unstructured":"Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids. Diabetes. 2013;62(12):4184\u201391.","journal-title":"Diabetes"},{"issue":"2","key":"1021_CR49","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1152\/ajpendo.00409.2016","volume":"313","author":"E Bertaggia","year":"2017","unstructured":"Bertaggia E, Jensen KK, Castro-Perez J, Xu Y, Di Paolo G, Chan RB, et al. Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption. Am J Physiol Endocrinol Metab. 2017;313(2):E121\u201333.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"suppl_1","key":"1021_CR50","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1093\/advances\/nmy063","volume":"10","author":"J Plaza-Diaz","year":"2019","unstructured":"Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019;10(suppl_1):S49\u201366.","journal-title":"Adv Nutr"},{"issue":"19","key":"1021_CR51","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.3390\/nu15194104","volume":"15","author":"R Kou","year":"2023","unstructured":"Kou R, Wang J, Li A, Wang Y, Zhang B, Liu J, et al. Ameliorating effects of Bifidobacterium longum subsp. infantis FB3\u201314 against high-fat-diet-induced obesity and gut microbiota disorder. Nutrients. 2023;15(19):4104.","journal-title":"Nutrients"},{"issue":"3","key":"1021_CR52","doi-asserted-by":"publisher","first-page":"e2100639","DOI":"10.1002\/mnfr.202100639","volume":"66","author":"L Ma","year":"2022","unstructured":"Ma L, Zheng A, Ni L, Wu L, Hu L, Zhao Y, et al. Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-fat diet-induced obese mice. Mol Nutr Food Res. 2022;66(3):e2100639.","journal-title":"Mol Nutr Food Res"},{"key":"1021_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","volume":"34","author":"S Wang","year":"2021","unstructured":"Wang S, Sheng F, Zou L, Xiao J, Li P. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism. J Adv Res. 2021;34:109\u201322.","journal-title":"J Adv Res"},{"key":"1021_CR54","doi-asserted-by":"publisher","first-page":"115333","DOI":"10.1016\/j.jep.2022.115333","volume":"294","author":"X Li","year":"2022","unstructured":"Li X, Zhao W, Xiao M, Yu L, Chen Q, Hu X, et al. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. J Ethnopharmacol. 2022;294:115333.","journal-title":"J Ethnopharmacol"},{"key":"1021_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.796590","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Hou H, Wang X, Dai X, Zhang W, Tang Q, et al. Diammonium glycyrrhizinate ameliorates obesity through modulation of gut microbiota-conjugated BAs-FXR signaling. Front Pharmacol. 2021;12: 796590.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1021_CR56","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","volume":"151","author":"FJ Gonzalez","year":"2016","unstructured":"Gonzalez FJ, Jiang C, Patterson AD. An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease. Gastroenterology. 2016;151(5):845\u201359.","journal-title":"Gastroenterology"},{"key":"1021_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154733","volume":"113","author":"D Tawulie","year":"2023","unstructured":"Tawulie D, Jin L, Shang X, Li Y, Sun L, Xie H, et al. Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism. Phytomedicine. 2023;113: 154733.","journal-title":"Phytomedicine"},{"issue":"3","key":"1021_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.idairyj.2009.10.003","volume":"20","author":"H-S Lye","year":"2010","unstructured":"Lye H-S, Rahmat-Ali GR, Liong M-T. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20(3):169\u201375.","journal-title":"Int Dairy J"},{"issue":"5","key":"1021_CR59","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1517\/14712598.2013.758706","volume":"13","author":"ML Jones","year":"2013","unstructured":"Jones ML, Tomaro-Duchesneau C, Martoni CJ, Prakash S. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther. 2013;13(5):631\u201342.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1021_CR60","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen T, Jiang R, Zhao A, Wu Q, Kuang J, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33(4):791-803.e7.","journal-title":"Cell Metab"},{"issue":"3","key":"1021_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cells8030253","volume":"8","author":"Y-S Chen","year":"2019","unstructured":"Chen Y-S, Liu H-M, Lee T-Y. Ursodeoxycholic acid regulates hepatic energy homeostasis and white adipose tissue macrophages polarization in leptin-deficiency obese mice. Cells. 2019;8(3):253.","journal-title":"Cells"},{"key":"1021_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2021.109080","volume":"714","author":"F Xia","year":"2021","unstructured":"Xia F, Xiang S, Chen Z, Song L, Li Y, Liao Z, et al. The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. Arch Biochem Biophys. 2021;714: 109080.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"1021_CR63","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/microorganisms8060860","volume":"8","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Song B, Zheng C, Zhang S, Yan Z, Tang Z, et al. Flavonoids from mulberry leaves alleviate lipid dysmetabolism in high fat diet-fed mice: involvement of gut microbiota. Microorganisms. 2020;8(6):860.","journal-title":"Microorganisms"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-01021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-024-01021-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-024-01021-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T17:05:35Z","timestamp":1729271135000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-024-01021-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1186\/s13020-024-01021-w","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Animal Ethical Committee of Shanghai University of Traditional Chinese Medicine (Approval No. PZSHUTCM2311210007, Date: 14th Nov. 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no potential conflicts of interest about the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}